1.
Activity of Belinostat in patients with recurrent or refractory peripheral or cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 11 [cited 2026 Jun. 2];3(1). Available from: https://journals.pagepress.net/hmr/article/view/527